TERN

Terns Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 6/10
  • Momentum↑ 9/10
Terns Pharmaceuticals sales and earnings growth
TERN Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 13.56%
  • FCF Y/Y↓ -3.80%
Terns Pharmaceuticals gross and profit margin trends
TERN Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↓ -55.60%
Terns Pharmaceuticals net debt vs free cash flow
TERN Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Terns Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗